Sensorion S.A.

Regeneron Pharmaceuticals, Inc. 's acquisition of Decibel Therapeutics, Inc. last year is looking like a very smart move after the gene therapy at the heart of the deal restored hearing to normal le

A lack of approved pharmacological therapies for hearing loss, whether acquired or congenital, is a gap in the market that a number of biotechs and big pharmaceutical firms are looking to plug. While

There are no approved pharmacological therapies for congenital hearing loss and this situation is unlikely to change any time soon. Still, a glimmer of hope has been provided with signs of hearing imp

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Dragonfly Takes Back IL-12 Immunotherap